Inventor
OTTOBONI THOMAS B
US53 patents
⚠️ This page may combine multiple inventors who share the name “OTTOBONI THOMAS B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HERON THERAPEUTICS INC
32 patentsUS11173118B2Nov 16, 2021
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
HERON THERAPEUTICS INC13 citations94
US10953018B2Mar 23, 2021
Emulsion formulations of aprepitant
HERON THERAPEUTICS INC12 citations94
US10624850B2Apr 21, 2020
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
HERON THERAPEUTICS INC12 citations94
US10500208B2Dec 10, 2019
Emulsion formulations of aprepitant
HERON THERAPEUTICS INC15 citations94
US9974742B2May 22, 2018
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
HERON THERAPEUTICS INC18 citations94
US9974793B2May 22, 2018
Emulsion formulations of aprepitant
HERON THERAPEUTICS INC18 citations94
US9808465B2Nov 7, 2017
Emulsion formulations of aprepitant
HERON THERAPEUTICS INC23 citations94
US9561229B2Feb 7, 2017
Emulsion formulations of aprepitant
HERON THERAPEUTICS INC22 citations94
US9974794B2May 22, 2018
Emulsion formulations of aprepitant
HERON THERAPEUTICS INC14 citations92
US9694079B2Jul 4, 2017
Long-acting polymeric delivery systems
HERON THERAPEUTICS INC19 citations92
US11878074B2Jan 23, 2024
Methods of use of emulsion formulations of an NK-1 receptor antagonist
HERON THERAPEUTICS INC7 citations86
US11744800B2Sep 5, 2023
Methods of use of emulsion formulations of an NK-1 receptor antagonist
HERON THERAPEUTICS INC7 citations86
US10213510B2Feb 26, 2019
Long-acting polymeric delivery systems
HERON THERAPEUTICS INC10 citations83
US9801945B2Oct 31, 2017
Long-acting polymeric delivery systems
HERON THERAPEUTICS INC9 citations83
US9592227B2Mar 14, 2017
Compositions of a polyorthoester and an aprotic solvent
HERON THERAPEUTICS INC3 citations82
US9446036B2Sep 20, 2016
Compositions of a polyorthoester and an aprotic solvent
HERON THERAPEUTICS INC5 citations80
US11413350B2Aug 16, 2022
Long-acting polymeric delivery systems
HERON THERAPEUTICS INC3 citations72
US11253504B2Feb 22, 2022
Compositions of a polyorthoester and an aprotic solvent
HERON THERAPEUTICS INC1 citations72
US11083797B2Aug 10, 2021
Long-acting polymeric delivery systems
HERON THERAPEUTICS INC1 citations72
US11083730B2Aug 10, 2021
Long-acting polymeric delivery systems
HERON THERAPEUTICS INC2 citations72
US10898575B2Jan 26, 2021
Long-acting polymeric delivery systems
HERON THERAPEUTICS INC3 citations72
US10632199B2Apr 28, 2020
Long-acting polymeric delivery systems
HERON THERAPEUTICS INC3 citations72
US10398686B2Sep 3, 2019
Compositions of a polyorthoester and an aprotic solvent
HERON THERAPEUTICS INC2 citations72
US10098957B2Oct 16, 2018
Long-acting polymeric delivery systems
HERON THERAPEUTICS INC3 citations72
US9913909B2Mar 13, 2018
Compositions of a polyorthoester and an aprotic solvent
HERON THERAPEUTICS INC2 citations71
US12318376B2Jun 3, 2025
Compositions of a polyorthoester and an aprotic solvent
HERON THERAPEUTICS INC0 citations62
US12290520B2May 6, 2025
Methods of use of emulsion formulations of aprepitant
HERON THERAPEUTICS INC0 citations62
US12115254B2Oct 15, 2024
Methods of use of emulsion formulations of an NK-1 receptor antagonist
HERON THERAPEUTICS INC0 citations62
US12115255B2Oct 15, 2024
Methods of use of emulsion formulations of an NK-1 receptor antagonist
HERON THERAPEUTICS INC0 citations62
US11844837B2Dec 19, 2023
Compositions of a polyorthoester and an organic acid excipient
HERON THERAPEUTICS INC0 citations62
US10980886B2Apr 20, 2021
Compositions of a polyorthoester and an organic acid excipient
HERON THERAPEUTICS INC1 citations62
US9744163B2Aug 29, 2017
Compositions of a polyorthoester and an aprotic solvent
HERON THERAPEUTICS INC1 citations59
POINT BIOMEDICAL CORP
6 patentsUS6039967AMar 21, 2000
Intravesical drug delivery system
POINT BIOMEDICAL CORP123 citations99
US6524608B2Feb 25, 2003
Intravesical drug delivery system
POINT BIOMEDICAL CORP82 citations98
US6896659B2May 24, 2005
Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
POINT BIOMEDICAL CORP90 citations97
US6193951B1Feb 27, 2001
Microparticles useful as ultrasonic contrast agents
POINT BIOMEDICAL CORP117 citations97
US6482518B1Nov 19, 2002
Excipient for the lyophilization of aqueous suspensions of microparticles
POINT BIOMEDICAL CORP24 citations92
US6776761B2Aug 17, 2004
Hollow microspheres with controlled fragility for medical use
POINT BIOMEDICAL CORP11 citations73
CLOROX CO
3 patents(unassigned)
2 patentsINSITE VISION INC
2 patentsSOANE TECHNOLOGIES INC
2 patentsVITAPHORE CORP
1 patent2C OPTICS INC
1 patentVITAPHORE CORP C O INTEGRA LIF
1 patentShowing the top 50 of 53 patents by PatentIndex Score.